Popular Articles

Anadys Pharmaceuticals Receives FDA Clearance Of Phase II Protocol To Study ANA598 In Combination With Interferon-Alpha And Ribavirin In HCV Patients
Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced finalization of the protocol for the Company"s Phase II trial of ANA598 in combination with pegylated interferon-alpha and ribavirin in hepatitis C patients. Allowance of the protocol has been received from the United States Food and Drug Administration (FDA), and patient dosing is expected to commence within the next several weeks.
pharmacy online Dentisti fiume
Rush University Medical Center Only Illinois Hospital To Receive Perfect Rating On Healthcare Equality Index
Rush University Medical Center is the only hospital in Illinois and the only hospital in the Midwest to receive the highest possible rating in the Healthcare Equality Index 2009 (HEI), which is an annual survey that evaluates the nation"s hospitals on their treatment of lesbian, gay, bisexual, and transgender (LGBT) patients, their families and hospital employees.
News of the day
Atrium Medical Receives CE Mark For Its CinatraTM CoCr Coronary Stent System
Atrium Medical is pleased to announce that is has received CE Mark for a new generation Cobalt Chromium Coronary Stent System called Cinatra™. Cinatra™ is indicated for the treatment of coronary artery occlusive disease.
Diagnostics

Stroke Rehab: Improving Impaired Attention May Help Patients Recover From Stroke

It may be possible to improve impaired attention after stroke - which could aid recovery - according to research reported in Stroke: Journal of the American Heart Association. Impaired attention is the most prominent stroke-related neuropsychological change and is reported in at least 46 percent and as many as 92 percent of stroke survivors, said Suzanne L. Barker-Collo, Ph.D., a senior lecturer and neuropsychologist at the University of Auckland in New Zealand. Impaired attention can reduce cognitive productivity and the ability to focus on tasks. It"s key to re-learning motor skills. In the first full-scale single-blinded, randomized clinical trial using Attention Process Training (APT), 78 stroke survivors were randomized to receive APT or standard rehabilitation care. APT is designed to improve the ability to maintain attention, as well as to shift attention (such as when having a conversation with more than one person) and to attend to more than one thing at a time. It"s been used successfully in people after traumatic brain injuries but hasn"t been tested in stroke patients. Researchers tested participants in four aspects of attention - sustained, selective, divided and alternating - as well as visual and auditory aspects of attention. Patients receiving APT had up to 30 hours of individual training, in one-hour sessions for four weeks. They received on average 14 hours of training. Researchers said people who underwent APT had a significantly greater improvement on a test of attention than those who received standard care. At six months, those who had APT had an average improvement of 2.49 standard deviations higher than standard care patients on "full-scale attention scores." The improvement in attention didn"t correlate with significant improvements in outcomes, but researchers said six months may not be enough time to gauge the impact of improved attention. Differences on other measures of attention and broader outcomes were not significant. Early identification and rehabilitation of attention should be part of stroke rehabilitation because APT is a viable and effective way to improve attention deficits after stroke, said the researchers, who recommend more research on the issue. See the manuscript for co-authors and author disclosures. The New Zealand Health Research Council funded the study. Bridgette McNeill American Heart Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):